Max Wang, CEO and the Head of the R&D DepartmentOur Core Offering: The Media Optimization & Development (MOD) Service
When off-the-shelf media are not enough, our MOD service is your definitive pathway to a bespoke, high-performance solution. We partner with you to design and deliver optimized media formulations that target your specific cell line and process goals—maximizing final titer and critical quality attributes (CQAs).
• Accelerated Timelines for Faster Commercialization: Our data-driven approach, powered by proprietary AI models and extensive platform data, compresses development cycles. We have consistently helped clients achieve 3 to 8-fold increases in titer within months, dramatically shortening the critical path from clone to clinic.
• Cost Optimization Through Precision Formulation: By identifying the exact nutritional requirements and limitations of your process, we eliminate unnecessary components and inefficiencies. This precision engineering translates into a more cost-effective media that enhances productivity without compromising quality.
• Built for Stable, Scalable Supply from the Start: Every MOD project is developed with manufacturability in mind. Our formulations are seamlessly transferred to our Medium Process Development (MPD) Platform, ensuring robust, scalable production with rigorous batch-to-batch consistency, securing your supply chain from clinical trials to commercial launch.
The Five Integrated Platforms Powering MOD Excellence
Our MOD service draws its unique strength from a foundation of five interlinked, proprietary technical platforms:
1. Raw Material Characterization Platform: Ensures unparalleled starting quality and consistency through advanced analytical control of every raw material, building a reliable supply chain foundation.
3. Cell Culture Technology (CCT) Platform: Provides the essential biological validation across diverse systems—from fed-batch and perfusion to viral vector production—ensuring your custom media performs flawlessly in your actual process.
4. Analytical & Testing Technology Platform: Guarantees safety and efficacy through deep analytical insight. Our high-throughput mass spectrometry capabilities deliver full-component analysis of media and spent culture fluid for precise optimization.
5. Medium Process Development (MPD) Platform: The critical bridge from formula to reliable product. It transforms optimized formulations into stable, manufacturable powder or liquid media at scale (up to 600kg powder / 2000L liquid batches), ensuring consistent performance in your facility.
-
We believe the success of a biotherapeutic product begins with a precise, scalable, and stable media strategy. Our integrated platforms and MOD service deliver customized, scalable solutions that accelerate time-to-market, optimize costs, and ensure supply chain reliability, turning scientific potential into commercial reality.
Comprehensive Support for Your Bioprocess Journey
Beyond MOD, we offer specialized services to support your entire workflow:
• Standardized Cell Culture Media: High-performance, ready-to-use media for CHO, HEK293, and MSC platforms.
• Customized Manufacturing: Rapid scale-up of your proprietary formula via our Rapid Powder Production (RPP) or Efficient Hydrate Solution (EHS) services.
• Spent Media Analysis (SMA): A data-driven service to diagnose process bottlenecks and enable continuous improvement.
Your Partner in Bioprocess Innovation
The experts at Shanghai MediumBank are committed to being your strategic partner. We combine advanced science with commercial pragmatism to deliver solutions that are not only technically superior but also commercially astute—designed to reduce risk, control cost, and accelerate your critical timelines.
Contact us today at mediumbank@mediumbank.net to discover how our MOD service and integrated platforms can power your next breakthrough.
